| Autor: |
Vicki, Seyfert-Margolis, Trang D, Gisler, Adam L, Asare, Richard S, Wang, H Michael, Dosch, Barbara, Brooks-Worrell, George S, Eisenbarth, Jerry P, Palmer, Carla J, Greenbaum, Stephen E, Gitelman, Gerald T, Nepom, Jeffrey A, Bluestone, Kevan C, Herold |
| Rok vydání: |
2006 |
| Předmět: |
|
| Zdroj: |
Diabetes. 55(9) |
| ISSN: |
0012-1797 |
| Popis: |
Type 1 diabetes is a chronic autoimmune disease mediated by autoreactive T-cells. Several experimental therapies targeting T-cells are in clinical trials. To understand how these therapies affect T-cell responses in vivo, assays that directly measure human T-cell function are needed. In a blinded, multicenter, case-controlled study conducted by the Immune Tolerance Network, we tested responses in an immunoblot and T-cell proliferative assay to distinguish type 1 diabetic patients from healthy control subjects. Peripheral blood cells from 39 healthy control subjects selected for DR4 and 23 subjects with recently diagnosed type 1 diabetes were studied. Autoantibody responses were measured in serum samples. Positive responses in both assays were more common in peripheral blood mononuclear cells from new-onset type 1 diabetic patients compared with control subjects. The proliferative, immunoblot, and autoantibody assays had sensitivities of 58, 91, and 78% with specificities of 94, 83, and 85%, respectively. When cellular assays were combined with autoantibody measurements, the sensitivity of the measurements was 75% with 100% specificity. We conclude that cellular assays performed on peripheral blood have a high degree of accuracy in discriminating responses in subjects with type 1 diabetes from healthy control subjects. They may be useful for assessment of cellular autoimmune responses involved in type 1 diabetes. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
